GlassScriptPhysician profile
Anya Khan
NPI 1699542092
$2,901.69
in general payments reported to CMS, 2019-2025
38 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 93% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,014 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $685.38 | 2024-2025 | Farxiga, Fasenra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $251.26 | 2024-2025 | |
| Abbvie INC. | $178.47 | 2024-2025 | |
| Axsome Therapeutics, INC. | $152.58 | 2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $119.32 | 2024 | Voquezna |
| Exact Sciences Corporation | $114.23 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Scilex Pharmaceuticals INC. | $106.48 | 2024-2025 | |
| Intuitive Surgical, INC. | $103.24 | 2025 | |
| Xeris Pharmaceuticals, INC. | $92.58 | 2025 | Recorlev |
| Amgen INC. | $85.11 | 2024-2025 | Evenity, Prolia, Otezla |
| Geron Corporation | $81.88 | 2025 | Rytelo |
| Corcept Therapeutics | $80.99 | 2024-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $71.51 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $59.99 | 2025 | Libtayo |
| Dexcom, INC. | $49.28 | 2024 | Dexcom G6 Transmitter |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $47.74 | 2025 | Provenge |
| Tandem Diabetes Care, INC. | $47.55 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Takeda Pharmaceuticals U.S.A., INC. | $46.22 | 2025 | Iclusig, Alunbrig |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.12 | 2024-2025 | Jardiance |
| Incyte Corporation | $41.54 | 2025 | Jakafi, Zynyz, Monjuvi |
| Sobi, INC | $39.96 | 2025 | |
| Pfizer INC. | $38.83 | 2025 | |
| Janssen Biotech, INC. | $32.71 | 2025 | Rybrevant, Talvey, Darzalex |
| Esperion Therapeutics, INC. | $32.63 | 2024 | Nexletol |
| Adc Therapeutics America, INC. | $32.38 | 2025 | |
| Novo Nordisk INC | $30.73 | 2024 | Ozempic |
| Jazz Pharmaceuticals INC. | $28.49 | 2025 | |
| Emd Serono, INC. | $25.57 | 2025 | |
| Daiichi Sankyo INC. | $23.54 | 2025 | Datroway |
| Insulet Corporation | $21.88 | 2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $20.34 | 2025 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $19.22 | 2024 | Rexulti |
| Aveo Pharmaceuticals, INC. | $18.27 | 2025 | |
| Antares Pharma, INC. | $16.38 | 2024 | Xyosted |
| Genentech USA, INC. | $16.22 | 2025 | Tecentriq |
| E.R. Squibb & Sons, L.L.C. | $15.89 | 2025 | Opdivo |
| Aimmune Therapeutics, INC. | $15.59 | 2025 | Zenpep |
| Idorsia Pharmaceuticals US INC | $13.59 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anya Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.